Delcath Systems Inc (DCTH)

Delcath Systems Inc (DCTH) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $534M; returns 1 day -2.2%, 1 week +2.4%, 1 year +38.9%.

Delcath Systems Inc. is an interventional oncology company focused on developing and commercializing proprietary products for the treatment of primary and metastatic cancers of the liver.

Groups DCTH belongs to

• Shrinking Share Count
• Oncology
• Liver Disease
• Biotechnology
• Healthcare
• Commercial Stage
• Commercial Stage Biotech
• Cancer Therapeutics
• Medical Devices
• Pharmaceuticals
• Minimally Invasive Surgery
• Healthcare Innovation
• Biopharmaceutical

DCTH financial model: income statement, cash flow and balance sheet